FDA 483 - Veterinary Pharmacy Corporation - March 19, 2026

During an inspection, Veterinary Pharmacy Corporation, a veterinary compounding pharmacy in Saint Peter, MN, was cited for significant contamination issues in its production areas, including damaged facilities and improper handling of Amoxicillin. The firm also failed to conduct adequate aseptic process simulations for sterile products and did not comply with a consent decree requiring endotoxin and pyrogen testing for each lot of sterile product.